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Abstract
Purpose Core decompression (CD) of the femoral head is performed to preserve the hip in avascular necrosis (AVN). The
outcome following this procedure differs based on the medical centre and the technique. Also, the time to total hip replacement
(THR) and the percentage of patients subsequently undergoing a THR are controversial.
Methods A systematic review was performed following PRISMA guidelines. The search included CENTRAL, MEDLINE,
EMBASE, Scopus, AMED and Web of Science Core Collection databases. Studies reporting the outcome of CD for AVN were
assessed. Studies using additional implants, vascularized grafts or any type of augmentation were excluded. Quality assessment
was performed using the Joanna Briggs Institute Critical Appraisal Checklist (JBI CAC) tool.
Trial registration International prospective register of systematic reviews (PROSPERO) - CRD42018100596.
Results A total of 49 studies describing 2540 hips were included. The mean weighted follow-up time was 75.1 months and the
mean age at surgery was 39 years. Twenty-four of 37 studies reported improvement in all outcome scores, whilst 9/37 studies
report only partial improvement post-operatively. Four studies (4/37) described poor clinical outcomes following intervention.
Data was pooled from 20 studies, including 1134 hips with a weighted mean follow-up of 56 months. The percentage of hips
undergoing THR averaged 38%. The time to THR had a weighted mean of 26 months after CD.
Conclusion Pooled results from 1134 hips and of these nearly 80% with early stage of osteonecrosis, showed that approximately
38% of patients underwent a total hip replacement at an average of 26 months following core decompression without augmentation.
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Introduction
Osteonecrosis or avascular necrosis (AVN) of the femoral
head is a challenging condition that ultimately leads to patients
undergoing a total hip replacement (THR) [1]. These patients
are young and therefore usually require further revision hip
replacements and multiple surgical procedures [2]. The
aetiology for AVN is varied and includes a variety of conditions
that lead to a compromised blood supply of the femoral head.
These include oral corticosteroids, excessive alcohol consump-
tion, Gaucher disease, sickle cell anemia, trauma, thrombosis
and systemic lupus erythematosus and in a large proportion of
patients, a cause cannot be established and is therefore termed
idiopathic [3]. Furthermore, the staging systems for progression
of disease are different across the literature and pose a signifi-
cant challenge in stratifying disease, defining surgical indica-
tions and establishing outcomes [4]. The most common
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classification systems in use are Ficat [5] /Modified Ficat [6],
University of Pennsylvania/Steinberg [4] and ARCO
(Association Research Circulation Osseous) [7–9].
Core decompression is a surgical intervention that is used
early in the disease process. The procedure potentially de-
creases the intraosseous pressure in the femoral head, relieves
pain and reestablishes blood flow helping healing of the ne-
crotic fragment. Multiple augmentation techniques with core
decompression have also been described and seem to further
improve outcomes [10, 11].
However, the eventual outcome and time to THR remains
controversial [12–14]. It is also not clear whether a mechani-
cal decompression in the form of core decompression alone is
sufficient and efficient enough in all stages of AVN to prevent
progression and delay the need for a THR.
The purpose of this study, therefore, was to assess the out-
comes and time to THR following core decompression of the
femoral head without any augmentation for non-traumatic
AVN.
Materials and methods
Search strategy and criteria
Two reviewers (OA and OW) searched the online databases
(CENTRAL (Cochrane Central Register of Controlled Trials),
MEDLINE, EMBASE, Scopus, AMED and Web of Science
Core Collection) for literature describing the outcomes of core
decompression without augmentation for non-traumatic AVN
of the femoral head. A total of eight combinations of the
following keywords were used: “femoral head” with
“osteonecrosis”, “avascular necrosis”, “aseptic necrosis”,
“avn” with the terms - “core decompression” or “surgery”.
The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines were used for designing
this study. All published studies from inception until January
1, 2020, were included in the systematic search. The protocol
of this systematic review has been registered in the interna-
tional prospective register of systematic reviews
( PROSPERO) und e r t h e r e g i s t r a t i o n n umbe r
CRD42018100596 and been published recently [15].
Study screening/data abstraction
A detailed search strategy and the inclusion and exclusion
criteria are shown in Table 1. Both the reviewers independent-
ly abstracted the relevant study data from the final pool of
included articles and recorded this data on a spreadsheet de-
signed a priori. Participant-specific demographics extracted
from each study included number of hips, age, gender, body
mass index (BMI), presumed primary aetiology, stage of dis-
ease, surgical technique, clinical outcome (with preoperative
and postoperative results where applicable), radiological out-
come, time to joint replacement (THR), average follow-up
and specific comments (if any).
Data extraction and quality assessment
The quality of the RCTs was evaluated as per the guidance of
the Cochrane Risk of Bias assessment tool. The quality of all
the studies was then assessed using the Joanna Briggs Institute
Critical Appraisal Checklist (JBI CAC) [16]. A scoring sys-
tem was then used per study such as studies that answered yes
to a question from the checklist scored 2, not clear scored 1
and no scored 0. Each score was then converted into a per-
centage to harmonize the scoring system.
Data analysis and synthesis
Statistical analyses were performed using SPSS (IBM SPSS
Statistics, Version 24.0; Chicago, Illinois) and Graphpad
Prism (Graphpad Software, Version 8; San Diego, California).
In order to explore heterogeneity and evaluate studies
based on possible confounders, forest plots were developed
for calculation of effect size and confidence intervals (95%).
For proportions of hips undergoing hip replacement, the
datasets were developed from calculated individual propor-
tions of studies and their confidence intervals. A random ef-
fect model was used. Heterogeneity was calculated using
Comprehensive Meta-Analysis v2 (CMA), NJ, 07631, USA.
According to all of included studies, the α level was set at
0.05, and all p values were two-tailed.
Interpretation of the forest plots
Forest plots were presented to summarize the data (Fig. 2).
Each horizontal line on a forest plot represents a case series
included in the analysis. The length of the line corresponds to
a 95% CI of the corresponding case series’ effect estimate.
The effect estimate is marked with a solid square. The size
of the square represents the weight that the corresponding
study exerts in the analysis. The I2 value represents the calcu-
lated heterogeneity. Values less than 50% represent mild to
moderate heterogeneity, whereas values greater than 50% rep-
resent substantial to considerable heterogeneity.
Results
Search results and demographics
The initial search yielded a total of 16411 studies. After re-
moving duplicates, there were 8362 articles. These were then
screened for eligibility against the inclusion and exclusion
criteria (Table 1) and finally, 49 articles [24–70] were
606 International Orthopaedics (SICOT) (2021) 45:605–613
included for the full-text review and definitive analysis (Fig.
1). The reasons for exclusion were noted and are described
separately in Suppl. Table 1.
A total of 2540 hips were included in the study. There were
1122 males (61.5%) and 702 females (38.5%). The mean
weighted follow-up time was 75.1 months and the mean age
at surgery of patients was 39 years. The main aetiologies of
AVN included the following: usage of corticosteroids (53.5%
of patients), idiopathic (23.1% of patients) and alcohol abuse
(22.5% of patients) (Suppl. Table 2). The techniques used for
Fig. 1 Flowchart of the
systematic search
Table 1 Study selection criteria
Inclusion criteria Exclusion criteria
•Human studies in English language from inception until January 1, 2020 •Non-English articles
•Minimum level IV case series studies using Oxford Centre for Evidence-Based Medicine
2011 Levels of Evidence
•Review/hypothesis/technique articles/oral presentations
or cadaveric/animal studies
•Established diagnosis of avascular necrosis of the femoral head, outcomes together with
decompression technique were reported
•Studies including patients who underwent previous
surgery
•At least 10 hips were evaluated •Patient population with sickle cell disease
•Patients were classified either based on aetiology or on the stage of the disease:
Ficat/Modified Ficat or University of Pennsylvania/Steinberg or ARCO
•Any type of augmentation was used (e.g. vascularized
bone grafts or bone marrow stem cells)
•Studies including patients with associated trauma or
labral tears
ARCO Association Research Circulation Osseous
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drilling during core decompression were varied. These includ-
ed simple or multiple drilling using different instruments of
different diameters (trephine, cannulated drills, K-wires and
Steinman pins with diverse diameters).
Classification systems
An accentuated heterogeneity was found among the classifi-
cation systems for staging of the disease. Majority of the stud-
ies, 20 (40%), used the original “Ficat” classification [24, 27,
29, 32, 34, 36, 41, 46, 48–52, 56–59, 61, 62, 67]. Ten studies
(20%) followed the “Modified Ficat” classification [12, 25,
31, 44, 47, 54, 55, 63, 65, 70] and other eleven (22%) [26,
28, 30, 37–39, 45, 60, 66, 68, 69] used the ARCO system.
Finally, nine studies (18%) [12, 13, 33, 35, 40, 42, 43, 53, 64]
applied the “Steinberg/University of Pennsylvania” classifica-
tion. There was a single study that reported the hips separately
using two classification systems (Modified Ficat/Steinberg)
[12].
Quality assessment
Quality assessment of the 49 studies revealed that there were
27 level IV studies (case series), 12 level III studies, seven
level II studies and three level I studies (RCTs—randomized
controlled trials). The Joanna Briggs Institute Critical
Appraisal Toolkit (JBI-CAT) included the assessment of
methodology and of the reported risk of bias (Suppl.
Table 2). The studies averaged a score of 82%, which is an
indicator of good quality with the majority of studies scoring
75% or more (37/49).
Clinical and radiological outcome
Thirty-seven out of 49 studies (76%) reported data on clinical
outcome. Various tools were used for assessment of outcomes
in these studies: Merle d’Aubigné-Postel, VAS (visual ana-
logue score), Harris hip score (HHS), WOMAC, SF36-
Physical, SF36-Mental, Lequesne Index and pain rating index
(PRI). There was an obvious lack of a unified reporting tools
which required further simplification to interpret the results.
As such, the outcomes were simplified down to a binary level:
clinical improvement yes or no and radiological progression:
yes or no. Post-operative clinical improvement was consid-
eredwhen there was any post-operative improvement reported
in the outcome scores. From these, 24/37 studies reported
improvement in all outcome scores, whilst 9/37 had only par-
tially achieved better scores post-operatively. Four studies
(4/37) described poor outcomes post-operatively. Time to
clinical deterioration was reported in 51% (25/49) of the stud-
ies, usually corresponding to the time to a THR.
Due to the lack of separate stratification of pre-operative
and post-operative radiological stages in the selected studies, a
meaningful statistical summary could not be outlined.
Therefore, only a descriptive analysis of the individual studies
was performed (Suppl. Table 3–6). The post-operative staging
usually mixed the entire cohort of patients, making it impos-
sible to determine which hips did not progress to a THR and
which did. However, there were some studies that reported the
amount or percentage of hips that did not deteriorate radiolog-
ically and these have been recorded in Suppl. Table (3–6).
Total hip replacement
Both percentage and time to THR following core decompres-
sion were documented in 20/49 studies and included a total of
1134 hips (Suppl. Table 7). The pre-operative staging includ-
ed 890/1134 (78.5%) of hips with early stages of avascular
necrosis and no signs of collapse: Ficat classification (6 stud-
ies): stage I and II—180/196, stage III and IV—16/196; mod-
ified Ficat classification (4 studies): stage I and II—217/300,
stage III and IV—83/300; Steinberg classification (3 studies):
stage I + II + III—299/402, stage IV + V + VI—103/402;
ARCO classification (7 studies): stage I and II—194/236,
stage III and IV—42/236.
At the final follow-upwith aweighted average of 56months,
431/1134 (38%) hips were converted to a THR at a calculated
weighted average time of 26.3 months (Suppl. Table 7).
The pooled proportion of hips undergoing total hip replace-
ment was 38% (95% confidence interval with lower limit of
35.3% to upper limit of 41.1%) from 20 studies with a total of
1134 cases. There was statistical significance regarding het-
erogeneity (I2 value > 80%, p < 0.0001) showing the incon-
sistency of methodological aspects between the studies in-
cluded in the analysis, which did not allow a detailed meta-
analysis (Fig. 2). For further stratification, studies were sepa-
rately evaluated based on the most probable confounders: in-
clusion of post-collapse stages in the study population (Suppl.
Fig. 1), design (prospective/retrospective) (Suppl. Fig. 2) and
average time to total hip replacement (early < 24 months and
late > 24 months) (Fig. 3). This could not, however, signifi-
cantly reduce the heterogeneity, as all I2 values were above
60%, which may represent substantial heterogeneity regard-
less of the abovementioned stratification efforts.
Discussion
Osteonecrosis of the femoral head is a devastating condition for
the young adult. Depending on severity of the disease, these
patients may require a THR at a particularly young age and are,
therefore, likely to require a revision and perhaps a re-revision
of their prosthesis at some point in their lives [17]. Early diag-
nosis, prompt intervention and refining of joint-preserving pro-
cedures are therefore especially important in order to avoid or at
least delay the need for joint replacement in this unique cohort.
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Deciding the best treatment algorithm for a young and active
patient presenting with avascular necrosis can be challenging. It
should commence with selecting a good classification system
from themany available that would offer accuracy in evaluating
Fig. 3 Forest plot differentiating studies with early conversion to total hip
arthroplasty (average time to THA < 24 months) versus late conversions
(average time to THA > 24 months). Event—conversion to THA (total
hip arthroplasty). The size of the square represents the weight that the
corresponding study exerts. I2–value of calculated heterogeneity
Fig. 2 Proportion forest plot of
studies reporting percentage of
hips undergoing total hip
replacement after core
decompression. Event—
conversion to THA (total hip
arthroplasty). The size of the
square represents the weight that
the corresponding study exerts.
I2—value of calculated
heterogeneity
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disease progression and stratifying the disease. The optimal
treatment of the pre-collapse stage of (ARCO stage 1 and 2)
avascular necrosis is controversial. Core decompression is the
most commonly performed procedure for treating pre-collapse
osteonecrosis, as it has also been shown to be the only cost-
effective technique [18, 19]. Increased intramedullary pressure
is considered to be at the root cause of the pathophysiology, as it
is thought to potentially block off the perfusion to the head of
the femur. CD works by drilling one or multiple tunnels from
the greater trochanter, through the femoral neck, and into the
subchondral bone of the femoral head thereby reducing the
intramedullary pressure, promoting blood supply and allowing
the necrotic segment to heal [20].
Our study shows that core decompression provides only
short-term clinical improvement and partial or complete pain
relief in most of the cases (33 out of 37 studies reported post-
operative clinical improvement). It should however be noted
that reduction of pain may be due to temporary reduction of
weight-bearing during the rehabilitation phase and further tri-
als evaluating this aspect are necessary. Our results also dem-
onstrates that approximately 38% of patients underwent a total
hip replacement at an average of 26 months following core
decompression without augmentation in a large and diverse
population with AVN of the femoral head of varied aetiology.
This review, however, could not determine whether core de-
compression alone can arrest disease progression due to lack
of stratification and heterogeneity of data.
Our study reveals that the risk of conversion to a THR is
fairly high in the shorter term with core decompression alone.
It remains to be seen whether augmentation procedures can
better these results and obviate the need for a THR in this
cohort of patients.
Previous studies looking at the outcomes following core
decompression either have gaps in the inclusion and exclusion
criteria, are limited by the number of cases included or have
mixed all augmentation techniques with core decompression
which makes it difficult to interpret the outcomes of core de-
compression alone as a surgical intervention [21–23]. Our
study represents an effort to summarize all the available evi-
dence, which describes core decompression of the femoral
head as a sole procedure without additional augmentation,
e.g. bone marrow grafting.
There are limitations of our study and most of them are
directly linked to the individual limitations of the included stud-
ies and heterogeneity of data. The reporting systems were high-
ly variable, from different clinical scores HHS/D’Aubigne/
VAS to differing classifications used for staging disease (Ficat
or its modification, Steinberg, ARCO). Furthermore, the con-
cept of “procedural success” was not absolute. Whilst most
studies considered the absence of radiological progression to
be the main finding that suggested success, other authors
interpreted clinical improvement as being a success, even in
the presence of radiographic deterioration. Not reporting the
outcome separately for every single stage subgroup was the
biggest challenge in assessment of radiological outcome.
Most studies reported the distribution of pre-operative and
post-operative radiological stages, without specifically describ-
ing which hips actually deteriorated, making it tedious to track
longitudinal change for each hip. As such, no conclusions could
be made regarding the implications of the preoperative area of
osteonecrosis. Also, the lack of granularity and the presence of
significant heterogeneity in the data analysed did not allow
stratification of outcome based on each specific aetiology (idi-
opathic/corticosteroids/alcohol abuse or other), as the post-
operative outcome was reported cumulative for all patients.
This is applied not only to clinical data or radiographic staging
but also to conversion rates to THA, which could not be ex-
tracted for each aetiology separately.
However, despite these limitations, the strengths of our study
are represented by the large patient pool and by the rigorous
exclusion criteria that was used. The collateral influence of
aetiology (traumatic), systemic disease (sickle cell crisis) or
technique heterogeneity (presence of augmentation or bone
grafts) was excluded. Also, there was a tenacious stratification
based on stage of the disease even in the presence of a variety of
classification systems which makes this study unique.
A significant amount of work has been done recently by the
ARCO group [7–9] to define the aetiology and arrive at a
consensus statement to revise the ARCO classification.
Going forward, this classification should be used universally,
along with a specific criterion for defining “procedural suc-
cess” to allow future studies to compare results and avoid
heterogeneity in data.
Despite a high degree of heterogeneity amongst studies,
core decompression alone achieved short-term clinical im-
provement in majority of the cases. Pooled results from
1134 hips and of these nearly 80% with early stage of
osteonecrosis, showed that approximately 38% of patients
underwent a total hip replacement at an average of 26 months
following core decompression without augmentation. Future
studies should report outcome by stratifying it based on pre-
operative stages as proposed by the ARCO group and post-
collapse stages of osteonecrosis should be excluded.
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